18 Platelet transfusion remains the mainstay of therapy for perioperative thrombocytopenia, but might be ineffective in specified populations, carry all of the risks of blood product transfusion, and are a scarce resource.19 With efficient TPO-RA treatment, patients with recognized thrombocytopenia undergoing elective methods could undergo pharmacologic platelet depend optimization ahead https://carlc085sxb8.ltfblog.com/profile